NYMOX PHARMACEUTICAL CORPORATION (NYMXF) Revenue 2016–2024
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2024 · since FY2016: $2.8M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $0 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $5,000 | -95.7% |
| FY2020 | $116,000 | -61.2% |
| FY2019 | $299,000 | +33.5% |
| FY2018 | $224,000 | -21.1% |
| FY2017 | $284,000 | -89.7% |
| FY2016 | $2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice